Delivery Order SPE2DE21D7009-SPE2D625F3HNB
- Not listed
- Boston Scientific Neuromodulation Corp, a subsidiary of Boston Scientific Corporation, has been awarded a delivery order valued at $41,430.34 for pain management medical devices and services. This fixed-price contract with economic price adjustment was awarded on September 9, 2025, with an ultimate completion date of September 19, 2025, and will be performed in Valencia, California. The award carries no set-aside designation, allowing the company to compete openly in the federal marketplace....
- Boston Scientific Neuromodulation Corp, a subsidiary of Boston Scientific Corporation, has been awarded a $41,406.68 fixed-price delivery order with economic price adjustment for pain management medical devices and services. The award, issued on September 9, 2025, with an ultimate completion date of September 16, 2025, carries no set-aside designation and will be performed in Valencia, California. This delivery order is issued under Boston Scientific Neuromodulation's larger indefinite...
- Boston Scientific Neuromodulation Corp, a subsidiary of Boston Scientific Corp, was awarded a delivery order valued at $36,589.22 on September 9, 2025, for pain management medical devices and services. This fixed-price contract with economic price adjustment has a completion date of September 19, 2025, and is being performed in Valencia, California. The award carries no set-aside designation, indicating open competition in the federal marketplace. The contract is funded through the Medical...
- Boston Scientific Neuromodulation Corp, a subsidiary of Boston Scientific Corporation, was awarded a $1,867 fixed-price delivery order with economic price adjustment on September 9, 2025, for pain management medical devices. The contract is set to be completed by September 16, 2025, with performance taking place in Valencia, California. This delivery order is issued under Boston Scientific Neuromodulation's larger indefinite delivery contract (SPE2DE) with the Defense Logistics Agency Troop...
- Boston Scientific Neuromodulation Corp, a subsidiary of Boston Scientific Corporation, has been awarded a fixed-price delivery order valued at $31,408.96 for pain management medical devices and equipment. The contract, awarded on July 24, 2025, with an ultimate completion date of July 31, 2025, carries no set-aside designation and will be performed in Valencia, California. The award is funded by the Medical Supply Chain, a defense-related procurement entity within the Department of Defense,...
- Boston Scientific Neuromodulation Corp, a subsidiary of Boston Scientific Corporation, received a delivery order valued at $1,825.75 for pain management medical devices and services. The contract, awarded on July 31, 2025, with an ultimate completion date of August 25, 2025, utilizes a fixed-price economic price adjustment pricing structure. The work will be performed in Valencia, California, and is funded by the Medical Supply Chain, a defense-related procurement entity within the Department of...
- Boston Scientific Neuromodulation Corp, a subsidiary of Boston Scientific Corporation, has been awarded a $1,867 fixed-price delivery order with economic price adjustment for pain management medical devices and services. The award, issued on August 19, 2025, with an ultimate completion date of August 26, 2025, represents a child contract under a larger indefinite delivery vehicle. Work will be performed in Valencia, California. This delivery order falls under the company's significant...
- Boston Scientific Neuromodulation Corp, a subsidiary of Boston Scientific Corporation, was awarded a delivery order valued at $1,948.40 on September 9, 2025, for pain management medical devices and services under a Defense Logistics Agency (DLA) Troop Support Medical contract. This fixed-price delivery order with economic price adjustment has an ultimate completion date of September 16, 2025, and will be performed at the contractor's facility in Valencia, California. The award is part of the...
- Boston Scientific Neuromodulation Corp, a subsidiary of Boston Scientific Corporation, received a $9,728.10 fixed-price delivery order with economic price adjustment for pain management products and services. The award, issued on August 8, 2025, with an ultimate completion date of August 15, 2025, represents a child contract with no set-aside designation. Work will be performed in Valencia, California. This delivery order falls under Boston Scientific Neuromodulation's larger indefinite delivery...
- The Department of Defense (DoD) awarded a fixed-price delivery order contract worth $2,748.75 to Boston Scientific Neuromodulation Corp, a subsidiary of Boston Scientific Corp, for pain management solutions. The contract, awarded by the Defense Logistics Agency (DLA) Troop Support Medical branch, has an ultimate completion date of April 23, 2024. The contract is not set aside and provides a range of neuromodulation products, including spinal cord stimulators, implantable pain pumps,...
- SPE2DE21D7009Indefinite Delivery Contract
- SPE2DE21D7009-SPE2D625F3HNBDelivery Order
Boston Scientific Neuromodulation Corp, a subsidiary of Boston Scientific Corp, has been awarded a delivery order valued at $43,751.07 for pain management medical devices and services. This fixed-price contract with economic price adjustment, awarded on September 9, 2025, with completion scheduled for September 19, 2025, represents work to be performed at the contractor's facility in Valencia, California. The contract carries no set-aside designation and is funded by the Medical Supply Chain, a defense-related procurement entity within the Department of Defense. This delivery order is issued under a larger single-award indefinite delivery contract (SPE2DE) valued at $83.1M between Boston Scientific Neuromodulation and the Defense Logistics Agency Troop Support Medical branch, which runs through August 16, 2026. Boston Scientific Neuromodulation specializes in advanced neuromodulation therapies and non-opioid pain management solutions for military treatment facilities and Veterans Affairs medical centers nationwide. The company's product portfolio includes spinal cord stimulation systems such as the RestoreSensor and Spectra WaveWriter stimulators, implantable pain pumps, radiofrequency ablation devices, and associated accessories and technical support. These devices are designed to address chronic pain management needs for service members and veterans, particularly those suffering from traumatic injuries, and represent a strategic alternative to opioid-based pain management approaches within the federal healthcare system.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $43.8k | 9/9/25 |